Early in the course, each participant will choose a drug recently approved by the FDA about which to learn more through a literature search. During the final meetings of the selective, each participant will provide a short 10 – 15 minute presentation to the group on the background of their chosen drug, highlighting the drug’s indication rationale and development through animal studies and clinical studies.